"10.1371_journal.pmed.1000099","plos medicine","2009-06-23T00:00:00Z","Naveed Sattar; Heather M Murray; Paul Welsh; Gerard J Blauw; Brendan M Buckley; Stuart Cobbe; Anton J M de Craen; Gordon D Lowe; J Wouter Jukema; Peter W Macfarlane; Michael B Murphy; David J Stott; Rudi G J Westendorp; James Shepherd; Ian Ford; Chris J Packard; for the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group","Division of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, Scotland; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland; Section of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, The Netherlands; Department of Pharmacology and Therapeutics, Cork University Hospital, Wilton, Cork, Ireland; Departments of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands","ICMJE criteria for authorship read and met: NS HMM PW GJB BMB SMC AJMdC GL JWJ PWM MBM DJS RGJW JS IF CJP. Agree with the manuscripts results and conclusions: NS HMM PW GJB BMB SMC AJMdC GL JWJ PWM MBM DJS RGJW JS IF CJP. Designed the experiments/the study: NS PW GJB BMB JWJ RGJW JS IF CJP. Analyzed the data: GJB BMB SMC GL JWJ PWM MBM DJS RGJW JS IF CJP. Collected data/did experiments for the study: NS HMM PW BMB AJMdC PWM RGJW IF CJP. Enrolled patients: GJB BMB AJMdC JWJ MBM RGJW JS. Wrote the first draft of the paper: NS PW. Contributed to the writing of the paper: NS HMM PW GJB BMB AJMdC GL JWJ PWM DJS RGJW JS IF CJP. Chaired Endpoints Committee for the PROSPER study, on which this article is based: SMC. Assay of fibrinogen and critical revision of article: GL. Leading investigator on Dutch team involved in PROSPER and coordinator of Dutch biobank: JWJ. Reviewed all study ECGs and was a member of the end points committee: PM. Endpoints committee member and adjudication of all possible vascular endpoints during the study: DJS. Director for the PROSPER study data centre and responsible for data capture, querying, and quality: IF.","SC received research funding and honoraria from Astra Zeneca, makers of rosuvastatin. JS is a consultant to Astra Zeneca, GlaxoSmithKline, MSD, and Pfizer, and is on the Speakers Bureau for Astra Zeneca and Pfizer.","2009","06","Naveed Sattar","NS",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
